Neuraxis reports second quarter 2024 financial results

Carmel, ind., aug. 09, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the second quarter period ended june 30, 2024.

NRXS Ratings Summary

NRXS Quant Ranking